Alcohol Use Disorder
Alcohol Use Disorder (AUD) is a medical condition characterized by an inability to control or stop drinking despite negative consequences, leading to significant impairment in daily life.
Alcohol Use Disorder: Psilocybin Treatment
We are studying if a single dose of psilocybin can help reduce heavy drinking in people with alcohol use disorder. This trial compares the effects of psilocybin to a placebo over 12 weeks.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 20 and 70 years old?
- Do you have a diagnosis of Alcohol Use Disorder (AUD)?
- Are you currently pregnant, breastfeeding, or planning to become pregnant?
- Are you taking any medications for Alcohol Use Disorder like disulfiram, naltrexone, or acamprosate?
- Do you have high blood pressure with systolic over 165 mmHg or diastolic over 95 mmHg?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Psilocybin
Psilocybe Cubensis
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Psykiatrisk Center Kobenhavn
Psychiatric Center Copenhagen
Copenhagen, Denmark
Sponsor: Psykiatrisk Center Kobenhavn
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.